As we reach the midpoint of the year, we are pleased to share the latest achievements, projects, and milestones that have shaped Biosfer Teslab’s activity during the second quarter of 2026. This edition highlights our continued commitment to scientific excellence, innovation, and collaboration in the fields of metabolomics and precision medicine.
Over the past three months, we have continued to strengthen our research capabilities, establish new partnerships, participate in leading scientific events, and expand our portfolio of services. These accomplishments reflect our dedication to delivering innovative solutions that support researchers, healthcare professionals, and industry partners in addressing today’s scientific and clinical challenges.
We hope this newsletter keeps you informed about our latest activities and inspires new opportunities for collaboration. Thank you for your continued interest in Biosfer Teslab and for joining us as we advance the future of metabolomics and precision medicine.
